Literature DB >> 17903849

Cavernous carotid aneurysms rarely cause subarachnoid hemorrhage or major neurologic morbidity.

Mark J Kupersmith1, Hadas Stiebel-Kalish, Ruth Huna-Baron, Avi Setton, Yasu Niimi, David Langer, Alejandro Berenstein.   

Abstract

GOAL: To determine whether aneurysms of the cavernous internal carotid artery (CCA) cause major neurologic morbidity or death.
METHODS: Retrospective analysis of all patients with a spontaneous CCA evaluated by a referral multidisciplinary neurovascular service from 1981 to 2000. All patients had complete clinical neuro-ophthalmologic and neurologic examinations and magnetic resonance imaging (MRI) or computed tomography (CT) with angiographic diagnostic confirmation. Follow-up evaluations were performed by our service in the majority of patients, and the remaining patients' subsequent examinations were obtained from the referring physicians.
RESULTS: One hundred seventy-four patients (mean age 60.7 years, median age 63 years, 161 women, 13 men) had 193 CCA. All 19 patients with bilateral CCAs were female. Twenty-eight patients had 1 or more subarachnoid aneurysms. The presentation included 156 aneurysms with pain or cranial neuropathy or both, 13 with a carotid cavernous fistula (CCF), and 24 asymptomatic CCAs. Two patients, both with a coagulopathy, had a cerebral infarct ipsilateral to the CCA, 1 at presentation and the other 2 years after partial third nerve palsy. One patient had a subarachnoid hemorrhage (SAH) 2.3 years after presentation, and no patient had arterial epistaxis or a CCA-related death. Excluding the 15 patients (16 aneurysms) who had no follow-up or died from SAH due to a subarachnoid aneurysm, 177 aneurysms were followed up for a mean duration of 3.10 years (SD = 3.6). One hundred six never-treated aneurysms were followed for 4.5 years (SD = 3.80, range 0.1-17), and 71 ultimately treated aneurysms were followed for 1.56 years (SD = 2.69, range 0.1-15). The overall rate for SAH was 0.19% and for a CCA-associated cerebral infarct was 0.37% per patient year. There were no correlations with cerebral infarct, SAH, or CCF and diabetes mellitus, hypertension, gender, age, cranial neuropathy, or size of the aneurysm, except for the largest diameter of the aneurysm and CCF (r = 0.17, P = .018). However, all of the patients with cerebral infarct or SAH and 12 of the 13 CCF had an aneurysm diameter > or = 1 cm.
CONCLUSIONS: CCA is a disorder with strong female gender bias that uncommonly causes major neurologic complications. These data suggest that CCA should not be included in analyses that determine the risk of severe neurologic morbidity, hemorrhage, or death due to intracranial aneurysms.

Entities:  

Year:  2002        PMID: 17903849     DOI: 10.1053/jscd.2002.123969

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  13 in total

1.  Cavernous sinus segment internal carotid artery aneurysms: whether and how to treat.

Authors:  K G ter Brugge
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

2.  Curvature effect on hemodynamic conditions at the inner bend of the carotid siphon and its relation to aneurysm formation.

Authors:  Alexandra Lauric; James Hippelheuser; Mina G Safain; Adel M Malek
Journal:  J Biomech       Date:  2014-07-10       Impact factor: 2.712

3.  Spontaneous subarachnoid hemorrhage due to ruptured cavernous internal carotid artery aneurysm after medical prolactinoma treatment.

Authors:  Siri Sahib Khalsa; Todd C Hollon; Ravi Shastri; Jonathan D Trobe; Joseph J Gemmete; Aditya S Pandey
Journal:  BMJ Case Rep       Date:  2016-06-08

4.  Detachable balloon embolization as the preferred treatment option for traumatic carotid-cavernous sinus fistula?

Authors:  Yin Niu; Tunan Chen; Jun Tang; ZhouYang Jiang; Gang Zhu; Zhi Chen
Journal:  Interv Neuroradiol       Date:  2019-08-26       Impact factor: 1.610

Review 5.  Cavernous carotid aneurysms in the era of flow diversion: a need to revisit treatment paradigms.

Authors:  O Tanweer; E Raz; A Brunswick; D Zumofen; M Shapiro; H A Riina; M Fouladvand; T Becske; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-21       Impact factor: 3.825

6.  Endovascular treatment of cavernous sinus aneurysms.

Authors:  W J van Rooij
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-27       Impact factor: 3.825

Review 7.  Suggested connections between risk factors of intracranial aneurysms: a review.

Authors:  Juan R Cebral; Marcelo Raschi
Journal:  Ann Biomed Eng       Date:  2012-12-14       Impact factor: 3.934

8.  Intrasellar rupture of a paraclinoid aneurysm with subarachnoid hemorrhage: usefulness of MR imaging in diagnosis.

Authors:  M Ribeiro; P Howard; R Willinsky; K ter Brugge; R Agid; L Thines; L da Costa
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-22       Impact factor: 3.825

9.  Cavernous carotid artery large aneurysm treated with a new flow diverter - Xcalibur aneurysm occlusion device (AOD).

Authors:  Richa Singh Chauhan; Nihar Vijay Kathrani; Karthik Kulanthaivelu; Chandrajit Prasad; Arun Kumar Gupta
Journal:  Interv Neuroradiol       Date:  2020-08-18       Impact factor: 1.610

10.  Embolization of direct carotid cavernous fistulas with the novel double-balloon technique.

Authors:  Yin Niu; Lin Li; Jun Tang; Gang Zhu; Zhi Chen
Journal:  Interv Neuroradiol       Date:  2015-11-18       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.